ATE140795T1 - Homobifunktionelle agenzien zur kupplung von enzymen un deren analogen an antikörper und deren analoge - Google Patents

Homobifunktionelle agenzien zur kupplung von enzymen un deren analogen an antikörper und deren analoge

Info

Publication number
ATE140795T1
ATE140795T1 AT91920049T AT91920049T ATE140795T1 AT E140795 T1 ATE140795 T1 AT E140795T1 AT 91920049 T AT91920049 T AT 91920049T AT 91920049 T AT91920049 T AT 91920049T AT E140795 T1 ATE140795 T1 AT E140795T1
Authority
AT
Austria
Prior art keywords
intrinsic factor
group
disclosed
solution
purified
Prior art date
Application number
AT91920049T
Other languages
English (en)
Inventor
Christopher Bieniarz
Christopher Welch
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE140795T1 publication Critical patent/ATE140795T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91920049T 1990-10-22 1991-10-18 Homobifunktionelle agenzien zur kupplung von enzymen un deren analogen an antikörper und deren analoge ATE140795T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60079590A 1990-10-22 1990-10-22

Publications (1)

Publication Number Publication Date
ATE140795T1 true ATE140795T1 (de) 1996-08-15

Family

ID=24405079

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91920049T ATE140795T1 (de) 1990-10-22 1991-10-18 Homobifunktionelle agenzien zur kupplung von enzymen un deren analogen an antikörper und deren analoge

Country Status (12)

Country Link
US (1) US5380873A (de)
EP (1) EP0555336B1 (de)
JP (2) JP3360174B2 (de)
KR (1) KR930702683A (de)
AT (1) ATE140795T1 (de)
AU (1) AU657284B2 (de)
CA (1) CA2094397C (de)
DE (1) DE69121108T2 (de)
DK (1) DK0555336T3 (de)
ES (1) ES2092579T3 (de)
GR (1) GR3021097T3 (de)
WO (1) WO1992007268A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0688364A4 (de) * 1993-03-09 1997-10-15 Abbott Lab Gentechnologisch hergestellte enzyme und ihre konjugate für diagnostische tests
US5548064A (en) * 1993-05-24 1996-08-20 Biotech Australia Pty Limited Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions
US6306665B1 (en) * 1999-10-13 2001-10-23 A-Fem Medical Corporation Covalent bonding of molecules to an activated solid phase material
US7193065B2 (en) * 2001-07-13 2007-03-20 Roche Diagnostics Operations, Inc. Protease inhibitor conjugates and antibodies useful in immunoassay
JP5628476B2 (ja) 2005-04-28 2014-11-19 ベンタナ・メデイカル・システムズ・インコーポレーテツド 抗体コンジュゲート
JP4793714B2 (ja) * 2005-05-19 2011-10-12 独立行政法人産業技術総合研究所 新規クロスリンカー化合物
ES2548518T3 (es) 2005-11-23 2015-10-19 Ventana Medical Systems, Inc. Conjugado molecular
WO2008136769A1 (en) * 2007-05-03 2008-11-13 Nanyang Technological University Online contaminant detection and removal system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340387C (en) * 1987-10-30 1999-02-09 Carol A. Schlesinger Heterobifunctional coupling agents
US5066490A (en) * 1988-06-01 1991-11-19 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Protein crosslinking reagents cleavable within acidified intracellular vesicles
US5104815A (en) * 1988-10-11 1992-04-14 Abbott Laboratories Assay for cobalamins
DE69030829T2 (de) * 1989-03-10 1998-01-15 Hoffmann La Roche Reagenzien zum Nachweis von Drogen

Also Published As

Publication number Publication date
JPH06502411A (ja) 1994-03-17
ES2092579T3 (es) 1996-12-01
US5380873A (en) 1995-01-10
DE69121108D1 (de) 1996-08-29
AU8905991A (en) 1992-05-20
WO1992007268A1 (en) 1992-04-30
EP0555336A4 (de) 1994-10-12
CA2094397A1 (en) 1992-04-23
DK0555336T3 (da) 1996-11-25
JP2000229926A (ja) 2000-08-22
EP0555336B1 (de) 1996-07-24
JP3488670B2 (ja) 2004-01-19
CA2094397C (en) 2005-10-04
EP0555336A1 (de) 1993-08-18
AU657284B2 (en) 1995-03-09
GR3021097T3 (en) 1996-12-31
JP3360174B2 (ja) 2002-12-24
DE69121108T2 (de) 1997-02-27
KR930702683A (ko) 1993-09-09

Similar Documents

Publication Publication Date Title
Campbell Human leukocyte elastase, cathepsin G, and lactoferrin: family of neutrophil granule glycoproteins that bind to an alveolar macrophage receptor.
Möhler et al. Properties of 3H-diazepam binding to benzodiazepine receptors in rat cerebral cortex
EP0097518A3 (en) Monoclonal antibody
DE3483869D1 (de) Zusammensetzungen zur bekaempfung von toxaemia.
ES8506902A1 (es) Un procedimiento para la purificacion de un antigeno.
NO20003716D0 (no) Protein D for anvendelse in vitro, renset antistoff som binder proteinet, samt anvendelser derav
ATE16567T1 (de) Intravenoes injektierbares globulin aus immunserum und verfahren zu seiner herstellung.
UA27763C2 (uk) Рекомбінантна молекула днк, що кодує молекулу адгезії icam-3, молекула адгезії icam-3, антитіло, здатне зв'язуватись з такою молекулою, фармацевтична композиція
DE69121108D1 (de) Homobifunktionelle agenzien zur kupplung von enzymen un deren analogen an antikörper und deren analoge
ES2182833T3 (es) Agentes antitromboticos multimeros polivalentes.
TR200001265T2 (tr) Vasp' a karşı antikorlar, bunların hazırlanması için hibridoma hücreleri.
GR3004988T3 (de)
FR2560212B1 (fr) Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
DE69633391D1 (de) KONJUGATE VON alpha-MSH MIT EINER FETTSÄURE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS MEDIKAMENT
ATE85058T1 (de) Jodhaltige polymere mit skeletten von dextran, verfahren zu ihrer herstellung und ihre verwendungen als kontrastmittel.
Amaral et al. Human liver nuclear transcortin its postulated role in glucocorticoid regulation of genetic activity
ATE22899T1 (de) Antithrombin-heparin komplex.
DE69115104D1 (de) Composition comprising at least two different antibodies or fragments thereof.
ATE395361T1 (de) Das h-y antigen
ATE69444T1 (de) N-substituierte-n-nitroso-aminoacetonitrile, verfahren zu ihrer herstellung und ihre verwendung.
WO1995032430A3 (en) Assay for pathogenicity of anti-dna antibodies
GB2214295B (en) "hapten determination method, use and components"
ATE43610T1 (de) Acino-foetale differenzierungsproteine verbunden mit krebs des pankreas, antiserum und monoklonale antikoerper gegen diese proteine und verfahren zu ihrer herstellung.
CA2180957A1 (en) Cloning and recombinant production of crf receptor(s)
KR910007963A (ko) pST의 일부분에 대응하는 아미노산 서열을 갖는 펩티드, 그에 대한 항체 및 pST 활성에 효력을 더하는 방법

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee